scispace - formally typeset
S

Scott C. Weaver

Researcher at University of Texas Medical Branch

Publications -  584
Citations -  40298

Scott C. Weaver is an academic researcher from University of Texas Medical Branch. The author has contributed to research in topics: Virus & Alphavirus. The author has an hindex of 92, co-authored 536 publications receiving 32230 citations. Previous affiliations of Scott C. Weaver include Mount Sinai St. Luke's and Mount Sinai Roosevelt & Lenox Hill Hospital.

Papers
More filters
Journal ArticleDOI

Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships.

TL;DR: Phylogenetic trees corroborated historical evidence that CHIK virus originated in Africa and subsequently was introduced into Asia and revealed that ONN virus is indeed distinct from CHIK viruses, and these viruses probably diverged thousands of years ago.
Journal ArticleDOI

Transmission cycles, host range, evolution and emergence of arboviral disease.

TL;DR: The mechanisms of disease emergence that are related to the host-range specificity of selected mosquito-borne alphaviruses and flaviviruses are reviewed.
Journal ArticleDOI

Zika virus: History, emergence, biology, and prospects for control.

TL;DR: Zika virus (ZIKV), a previously obscure flavivirus closely related to dengue, West Nile, Japanese encephalitis and yellow fever viruses, has emerged explosively since 2007 to cause a series of epidemics in Micronesia, the South Pacific, and most recently the Americas as discussed by the authors.
Journal ArticleDOI

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.

TL;DR: In this paper, three severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viruses containing key spike mutations from the newly emerged United Kingdom (UK) and South African (SA) variants: N501Y from UK and SA; 69/70 deletion + N 501Y+D614G from UK; and E484K from SA.
Journal ArticleDOI

An infectious cDNA clone of SARS-CoV-2

TL;DR: The reverse genetic system and reporter virus provide key reagents to study SARS-CoV-2 and develop countermeasures and were successfully used to evaluate the antiviral activities of interferon (IFN).